Quantcast

Latest cancer detection Stories

2009-09-28 08:48:00

Micromem Enters Breast Cancer Detection Market TORONTO and NEW YORK, Sept. 28 /PRNewswire-FirstCall/ - Micromem Technologies Inc. (Micromem) (OTC BB: MMTIF, CNSX: MRM), and its wholly owned subsidiary, Micromem Applied Sensor Technologies, Inc. (MASTInc), has received an initial purchase order for its sensors from Life Medical Technologies, Inc. (LMTI), which upon completion, will total US$30 million. Micromem anticipates delivery to begin in 2009 with the bulk expected in 2010, in...

2009-08-03 10:47:09

The use of digital mammography equipment alone is responsible for an increased number of breast cancers detected at a community-based mammography facility, according to a study performed at San Luis Diagnostic Center in San Luis Obispo, CA.Researchers found that there was a significant increase in the number of breast cancers detected following the switch from film-screen to digital mammography. The number of cancers detected prior to the switch averaged between 4.1-4.5 cancers per 1,000...

2009-06-09 07:00:00

Center will be the first in the world to integrate research on both in vivo and in vitro diagnostics to deliver blood and complementary imaging tests for solid tumor cancers PALO ALTO, Calif., June 9 /PRNewswire-USNewswire/ -- Canary Foundation, a nonprofit organization that funds research in early cancer detection, and Stanford University School of Medicine announced their commitment of $20 million to create the Canary Center at Stanford for Cancer Early Detection, a world-class research...

2009-06-02 09:40:47

Mayo Clinic researchers have demonstrated that a noninvasive screening test can detect not only colorectal cancer but also the common cancers above the colon -- including pancreas, stomach, biliary and esophageal cancers. This is one of more than 100 Mayo Clinic studies being presented at Digestive Disease Week 2009 in Chicago, May 30 "“ June 4.Gastrointestinal (GI) cancers account for approximately one in four cancer deaths. While high cure rates can be achieved with early-stage...

2009-04-06 09:00:00

Albuquerque the First of Five New Markets Slated to Feature MoleSafe Skin Cancer Detection Facilities in 2009 ALBUQUERQUE, N.M., April 6 /PRNewswire/ -- MoleSafe (www.molesafe.com), a company that offers an advanced skin cancer detection program, announced today it has opened its second U.S. location in Albuquerque, New Mexico. The company opened its first U.S. location in Millburn, New Jersey, in 2008. MoleSafe originated in New Zealand, which is the melanoma capital of the world. The...

2009-03-05 07:00:00

Colonoscopy Every Ten Years is Preferred Screening Strategy According, to Experts BETHESDA, Md., March 5 /PRNewswire-USNewswire/ -- The American College of Gastroenterology has issued updated screening guidelines for colorectal cancer in the March issue of The American Journal of Gastroenterology. The guideline offers new graded recommendations for screening in an update of those published by ACG in 2000. Key Recommendations in New ACG Colorectal Cancer Screening Guideline: Colonoscopy...

2009-02-10 09:18:26

Eric Seibel, a UW mechanical engineering associate professor, and his colleagues have worked in collaboration with VisionGate, Inc., a privately held company in Gig Harbor, Wash., that holds the patents on the technology. The machine works by rotating the cell under the microscope lens and taking hundreds of pictures per rotation, and then digitally combining them to form a single 3-D image.The 3-D visualizations could lead to big advances in early cancer detection, since clinicians today...

2008-10-30 12:01:04

Guided Therapeutics, Inc. (GT) (Pink Sheets: GTHP) and Konica Minolta Opto, Inc. (KMOT) of Tokyo, today announced that the two companies have extended an option to license and no shop agreement to co-develop certain of GT's non-invasive technologies. GT and KMOT expect to negotiate, and then sign, a definitive development agreement within approximately six months. A major focus of the agreement is expected to include jointly adapting GT's LightTouch(TM) non-invasive cervical cancer...

2008-09-30 12:00:48

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Sept. 30, 2008) - Perceptronix Medical Inc., a privately owned independent cytology laboratory specializing in early cancer detection tests, will present at the BioContact biopharmaceutical partnership symposium at Chateau Frontenac in Quebec City. The symposium will be held on October 2nd, 2008, at 2pm, Salle Petit Frontenac. Dr. Bojana Turic, President and CEO of Perceptronix will provide the Company overview and its' newest development and...

2008-09-26 09:00:40

Guided Therapeutics, a medical technology company, has completed its FDA pivotal clinical trial for its LightTouch non-invasive cervical cancer detection device. The GT LightTouch technology systematically and rapidly scans the cervix to identify cancers and pre-cancers painlessly and non-invasively by analyzing the wavelengths of light reflected from cervical tissue, the company said. Since the pivotal trial began, approximately 1,900 women have been tested to demonstrate the...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.